We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+5.06%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$8.36B
AUM Growth
+$811M
(+11%)
Cap. Flow
+$513M
Cap. Flow
% of AUM
6.13%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
2,400
New
687
Increased
686
Reduced
568
Closed
456
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$87.3M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$58.8M |
| 3 |
Wells Fargo
WFC
|
+$50M |
| 4 |
Archer Daniels Midland
ADM
|
+$46.7M |
| 5 |
Southern Company
SO
|
+$46.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$79.7M |
| 2 |
Cigna
CI
|
+$69.1M |
| 3 |
iShares MSCI Taiwan ETF
EWT
|
+$46.8M |
| 4 |
Caterpillar
CAT
|
+$42.7M |
| 5 |
DXC Technology
DXC
|
+$40M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.52% |
| 2 | Technology | 13.89% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 11.24% |
| 5 | Healthcare | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Intellia Therapeutics
NTLA
$1.5B
| $930K | 0.01% |
32,500
+5,671
| +21% | +$165K |
|
1027
Benchmark Electronics
BHE
$2.91B
| $928K | 0.01% |
39,670
+27,027
| +214% | +$713K |
|
|
BBBY
1028
Bed Bath & Beyond
BBBY
$473M
| $927K | 0.01% |
44,563
-256,862
| -85% | -$6.33M |
|
|
TRUE
1029
DELISTED
TrueCar
TRUE
| $922K | 0.01% |
+65,361
| New | +$800K |
|
1030
Ashland
ASH
$3.04B
| $921K | 0.01% |
+10,979
| New | +$916K |
|
1031
OneMain Financial
OMF
$6.9B
| $921K | 0.01% |
+27,402
| New | +$960K |
|
1032
Neurocrine Biosciences
NBIX
$17.7B
| $919K | 0.01% |
7,475
+2,183
| +41% | +$248K |
|
1033
Apogee Enterprises
APOG
$850M
| $918K | 0.01% |
22,222
+9,916
| +81% | +$479K |
|
1034
Euronet Worldwide
EEFT
$3.02B
| $918K | 0.01% |
+9,160
| New | +$863K |
|
1035
NCR Voyix
VYX
$1.06B
| $918K | 0.01% |
52,677
+23,699
| +82% | +$422K |
|
1036
Spectrum Brands
SPB
$2.04B
| $916K | 0.01% |
+12,256
| New | +$1.04M |
|
1037
Box
BOX
$4.02B
| $915K | 0.01% |
+38,258
| New | +$963K |
|
|
DFRG
1038
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
| $912K | 0.01% |
109,937
+63,087
| +135% | +$627K |
|
1039
V2X
VVX
$2.62B
| $908K | 0.01% |
29,100
+2,987
| +11% | +$96.3K |
|
|
TECD
1040
DELISTED
Tech Data Corp
TECD
| $906K | 0.01% |
12,654
+7,999
| +172% | +$648K |
|
1041
Fate Therapeutics
FATE
$281M
| $905K | 0.01% |
+55,532
| New | +$657K |
|
1042
Terreno Realty
TRNO
$7.68B
| $895K | 0.01% |
23,729
+7,929
| +50% | +$297K |
|
|
FLXN
1043
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $895K | 0.01% |
47,826
-22,876
| -32% | -$526K |
|
|
OPTU
1044
Optimum Communications Inc
OPTU
$316M
| $894K | 0.01% |
+49,300
| New | +$883K |
|
|
PENG
1045
Penguin Solutions Inc
PENG
$2.76B
| $893K | 0.01% |
62,162
-68,978
| -53% | -$1.07M |
|
1046
Karyopharm Therapeutics
KPTI
$168M
| $887K | 0.01% |
3,473
+2,493
| +254% | +$689K |
|
|
LPT
1047
DELISTED
Liberty Property Trust
LPT
| $883K | 0.01% |
20,905
-56,571
| -73% | -$2.46M |
|
1048
Enanta Pharmaceuticals
ENTA
$372M
| $881K | 0.01% |
10,304
-7,686
| -43% | -$770K |
|
1049
Insperity
NSP
$1.85B
| $881K | 0.01% |
+7,466
| New | +$811K |
|
|
ELLI
1050
DELISTED
Ellie Mae Inc
ELLI
| $881K | 0.01% |
+9,300
| New | +$954K |
|
Similar funds
Squarepoint's Q3 2018 Portfolio in Review
As of Q3 2018, Squarepoint held 2,400 positions worth $8.36B, up 11% from $7.55B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Squarepoint deployed $513M of net new capital in Q3 2018, opening 687 new positions and adding to 686 existing holdings. Its largest new stake was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Cigna, an estimated $69.1M trimmed.
- Squarepoint's largest Q3 2018 buy was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.
- Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q3 2018, an estimated $58.8M increase.
- Squarepoint's biggest Q3 2018 reduction was Cigna, cutting an estimated $69.1M.
- Squarepoint fully exited Vanguard FTSE Emerging Markets ETF in Q3 2018, selling an estimated $79.7M.
- Squarepoint's ten largest holdings make up 9.6% of its $8.36B portfolio in Q3 2018.
- Squarepoint opened 687 new positions and closed 456 in Q3 2018.
- Squarepoint's portfolio value rose 11% quarter-over-quarter to $8.36B.
Based on Squarepoint's 13F filing for Q3 2018, filed 14 Nov 2018.